Skip to main content
Erschienen in: World Journal of Surgery 6/2018

14.11.2017 | Original Scientific Report

Postoperative Albumin–Bilirubin Grade Change Predicts the Prognosis of Patients with Hepatitis B-Related Hepatocellular Carcinoma Within the Milan Criteria

verfasst von: Chuan Li, Xiao-Yun Zhang, Wei Peng, Tian-Fu Wen, Lu-Nan Yan, Bo Li, Jia-Yin Yang, Wen-Tao Wang, Ming-Qing Xu

Erschienen in: World Journal of Surgery | Ausgabe 6/2018

Einloggen, um Zugang zu erhalten

Abstract

Objective

Albumin–bilirubin (ALBI) grade has been validated as a simple, evidence-based, and objective prognostic tool for patients with hepatocellular carcinoma (HCC). However, minimal information is available concerning postoperative ALBI grade changes in HCC. This study aimed to investigate the prognostic value of postoperative ALBI grade changes in patients with hepatitis B virus (HBV)-related HCC within the Milan criteria after liver resection.

Methods

Patients with HBV-related HCC within the Milan criteria who underwent liver resection between 2010 and 2016 at West China Hospital were reviewed (N = 258). A change in ALBI grade was defined as first postoperative month ALBI grade–preoperative ALBI grade. If the value was >0, postoperative worsening of ALBI grade was considered; otherwise, stable ALBI grade was considered. Cox proportional hazard regression analyses were used to determine the factors that influence recurrence and survival.

Results

During the follow-up, 130 patients experienced recurrence and 47 patients died. Multivariate analyses revealed that postoperative worsening of ALBI grade (HR 1.541, 95% CI 1.025–2.318, P = 0.038), microvascular invasion (MVI, HR 1.802, 95% CI 1.205–2.695, P = 0.004), and multiple tumors (HR 1.676, 95% CI 1.075–2.615, P = 0.023) were associated with postoperative recurrence, whereas MVI (HR 2.737, 95% CI 1.475–5.080, P = 0.001), postoperative worsening of ALBI grade (HR 2.268, 95% CI 1.227–4.189, P = 0.009), high alpha-fetoprotein level (HR 2.055, 95% CI 1.136–3.716, P = 0.017), and transfusion (HR 2.597, 95% CI 1.395–4.834, P = 0.003) negatively influenced long-term survival. Patients with postoperative worsening of ALBI grade exhibited increased incidence of recurrence and worse long-term survival.

Conclusion

Postoperative worsening of ALBI grade was associated with increased recurrence and poorer overall survival for patients with HBV-related HCC within the Milan criteria. We should pay attention to liver function changes in HCC patients after liver resection.
Literatur
1.
Zurück zum Zitat Cabre N, Camps J, Joven J (2016) Inflammation, mitochondrial metabolism and nutrition: the multi-faceted progression of non-alcoholic fatty liver disease to hepatocellular carcinoma. Hepatobiliary Surg Nutr 5:438–443CrossRefPubMedPubMedCentral Cabre N, Camps J, Joven J (2016) Inflammation, mitochondrial metabolism and nutrition: the multi-faceted progression of non-alcoholic fatty liver disease to hepatocellular carcinoma. Hepatobiliary Surg Nutr 5:438–443CrossRefPubMedPubMedCentral
2.
Zurück zum Zitat Torre LA, Bray F, Siegel RL et al (2015) Global cancer statistics, 2012. CA Cancer J Clin 65:87–108CrossRefPubMed Torre LA, Bray F, Siegel RL et al (2015) Global cancer statistics, 2012. CA Cancer J Clin 65:87–108CrossRefPubMed
3.
Zurück zum Zitat Parkin DM, Bray F, Ferlay J et al (2005) Global cancer statistics, 2002. CA Cancer J Clin 55:74–108CrossRefPubMed Parkin DM, Bray F, Ferlay J et al (2005) Global cancer statistics, 2002. CA Cancer J Clin 55:74–108CrossRefPubMed
4.
Zurück zum Zitat Poon RT, Fan ST, Lo CM et al (2002) Long-term survival and pattern of recurrence after resection of small hepatocellular carcinoma in patients with preserved liver function: implications for a strategy of salvage transplantation. Ann Surg 235(373–38):2 Poon RT, Fan ST, Lo CM et al (2002) Long-term survival and pattern of recurrence after resection of small hepatocellular carcinoma in patients with preserved liver function: implications for a strategy of salvage transplantation. Ann Surg 235(373–38):2
5.
Zurück zum Zitat Johnson PJ, Berhane S, Kagebayashi C et al (2015) Assessment of liver function in patients with hepatocellular carcinoma: a new evidence-based approach-the ALBI grade. J Clin Oncol 33(550–55):8 Johnson PJ, Berhane S, Kagebayashi C et al (2015) Assessment of liver function in patients with hepatocellular carcinoma: a new evidence-based approach-the ALBI grade. J Clin Oncol 33(550–55):8
7.
Zurück zum Zitat Wang YY, Zhong JH, Su ZY et al (2016) Albumin–bilirubin versus Child–Pugh score as a predictor of outcome after liver resection for hepatocellular carcinoma. Br J Surg 103(725–73):4 Wang YY, Zhong JH, Su ZY et al (2016) Albumin–bilirubin versus Child–Pugh score as a predictor of outcome after liver resection for hepatocellular carcinoma. Br J Surg 103(725–73):4
8.
Zurück zum Zitat Toyoda H, Lai PB, O’Beirne J et al (2016) Long-term impact of liver function on curative therapy for hepatocellular carcinoma: application of the ALBI grade. Br J Cancer 114:744–775CrossRefPubMedPubMedCentral Toyoda H, Lai PB, O’Beirne J et al (2016) Long-term impact of liver function on curative therapy for hepatocellular carcinoma: application of the ALBI grade. Br J Cancer 114:744–775CrossRefPubMedPubMedCentral
9.
Zurück zum Zitat Li C, Zhu WJ, Wen TF et al (2014) Child–Pugh A hepatitis B-related cirrhotic patients with a single hepatocellular carcinoma up to 5 cm: liver transplantation vs. resection. J Gastrointest Surg 18:1469–1476CrossRefPubMed Li C, Zhu WJ, Wen TF et al (2014) Child–Pugh A hepatitis B-related cirrhotic patients with a single hepatocellular carcinoma up to 5 cm: liver transplantation vs. resection. J Gastrointest Surg 18:1469–1476CrossRefPubMed
11.
Zurück zum Zitat Yang SL, Liu LP, Yang S et al (2016) Preoperative serum alpha-fetoprotein and prognosis after hepatectomy for hepatocellular carcinoma. Br J Surg 103(716–72):4 Yang SL, Liu LP, Yang S et al (2016) Preoperative serum alpha-fetoprotein and prognosis after hepatectomy for hepatocellular carcinoma. Br J Surg 103(716–72):4
12.
Zurück zum Zitat Kauffmann R, Fong Y (2014) Post-hepatectomy liver failure. Hepatobiliary Surg Nutr 3(238–24):6 Kauffmann R, Fong Y (2014) Post-hepatectomy liver failure. Hepatobiliary Surg Nutr 3(238–24):6
13.
Zurück zum Zitat Hallet J, Karanicolas PJ, Zih FS et al (2016) Hypophosphatemia and recovery of post-hepatectomy liver insufficiency. Hepatobiliary Surg Nutr 5(217–22):4 Hallet J, Karanicolas PJ, Zih FS et al (2016) Hypophosphatemia and recovery of post-hepatectomy liver insufficiency. Hepatobiliary Surg Nutr 5(217–22):4
14.
Zurück zum Zitat Wrighton LJ, O’Bosky KR, Namm JP et al (2012) Postoperative management after hepatic resection. J Gastrointest Oncol 3(41–4):7 Wrighton LJ, O’Bosky KR, Namm JP et al (2012) Postoperative management after hepatic resection. J Gastrointest Oncol 3(41–4):7
15.
Zurück zum Zitat Zhao H, Chen C, Gu S et al (2017) Anatomical versus non-anatomical resection for solitary hepatocellular carcinoma without macroscopic vascular invasion: a propensity score matching analysis. J Gastroenterol Hepatol 32(870–87):8 Zhao H, Chen C, Gu S et al (2017) Anatomical versus non-anatomical resection for solitary hepatocellular carcinoma without macroscopic vascular invasion: a propensity score matching analysis. J Gastroenterol Hepatol 32(870–87):8
16.
Zurück zum Zitat Schlichtemeier SM, Pang TC, Williams NE et al (2016) A pre-operative clinical model to predict microvascular invasion and long-term outcome after resection of hepatocellular cancer: The Australian experience. Eur J Surg Oncol 42(1576–158):3 Schlichtemeier SM, Pang TC, Williams NE et al (2016) A pre-operative clinical model to predict microvascular invasion and long-term outcome after resection of hepatocellular cancer: The Australian experience. Eur J Surg Oncol 42(1576–158):3
17.
Zurück zum Zitat Lei Z, Li J, Wu D et al (2016) Nomogram for preoperative estimation of microvascular invasion risk in hepatitis B virus-related hepatocellular carcinoma within the Milan criteria. JAMA Surg 151(356–36):3 Lei Z, Li J, Wu D et al (2016) Nomogram for preoperative estimation of microvascular invasion risk in hepatitis B virus-related hepatocellular carcinoma within the Milan criteria. JAMA Surg 151(356–36):3
18.
Zurück zum Zitat Grazi GL, Cescon M, Ravaioli M et al (2003) Liver resection for hepatocellular carcinoma in cirrhotics and noncirrhotics. Evaluation of clinicopathologic features and comparison of risk factors for long-term survival and tumour recurrence in a single centre. Aliment Pharmacol Ther 17(Suppl 2):119–129CrossRefPubMed Grazi GL, Cescon M, Ravaioli M et al (2003) Liver resection for hepatocellular carcinoma in cirrhotics and noncirrhotics. Evaluation of clinicopathologic features and comparison of risk factors for long-term survival and tumour recurrence in a single centre. Aliment Pharmacol Ther 17(Suppl 2):119–129CrossRefPubMed
20.
Zurück zum Zitat Fukushima K, Fukumoto T, Kuramitsu K et al (2014) Assessment of ISGLS definition of posthepatectomy liver failure and its effect on outcome in patients with hepatocellular carcinoma. J Gastrointest Surg 18(729–73):6 Fukushima K, Fukumoto T, Kuramitsu K et al (2014) Assessment of ISGLS definition of posthepatectomy liver failure and its effect on outcome in patients with hepatocellular carcinoma. J Gastrointest Surg 18(729–73):6
21.
Zurück zum Zitat Nachnani JS, Hamid F, Pandya P et al (2010) Transfusion-related acute hepatic enzyme elevation: a new disease entity? Eur J Gastroenterol Hepatol 22:378CrossRefPubMed Nachnani JS, Hamid F, Pandya P et al (2010) Transfusion-related acute hepatic enzyme elevation: a new disease entity? Eur J Gastroenterol Hepatol 22:378CrossRefPubMed
23.
Zurück zum Zitat Motoyama H, Kobayashi A, Yokoyama T et al (2014) Liver failure after hepatocellular carcinoma surgery. Langenbecks Arch Surg 399(1047–105):5 Motoyama H, Kobayashi A, Yokoyama T et al (2014) Liver failure after hepatocellular carcinoma surgery. Langenbecks Arch Surg 399(1047–105):5
24.
Zurück zum Zitat Sima CS, Jarnagin WR, Fong Y et al (2009) Predicting the risk of perioperative transfusion for patients undergoing elective hepatectomy. Ann Surg 250(914–92):1 Sima CS, Jarnagin WR, Fong Y et al (2009) Predicting the risk of perioperative transfusion for patients undergoing elective hepatectomy. Ann Surg 250(914–92):1
26.
Zurück zum Zitat Pang Q, Qu K, Zhang JY et al (2015) The prognostic value of platelet count in patients with hepatocellular carcinoma: a systematic review and meta-analysis. Medicine (Baltimore) 94:e1431CrossRefPubMedCentral Pang Q, Qu K, Zhang JY et al (2015) The prognostic value of platelet count in patients with hepatocellular carcinoma: a systematic review and meta-analysis. Medicine (Baltimore) 94:e1431CrossRefPubMedCentral
27.
Zurück zum Zitat Tung-Ping Poon R, Fan ST, Wong J (2000) Risk factors, prevention, and management of postoperative recurrence after resection of hepatocellular carcinoma. Ann Surg 232:10–24CrossRefPubMedPubMedCentral Tung-Ping Poon R, Fan ST, Wong J (2000) Risk factors, prevention, and management of postoperative recurrence after resection of hepatocellular carcinoma. Ann Surg 232:10–24CrossRefPubMedPubMedCentral
28.
Zurück zum Zitat Bagirsakci E, Sahin E, Atabey N et al (2017) Role of albumin in growth inhibition in hepatocellular carcinoma. Oncology 93(136–14):2 Bagirsakci E, Sahin E, Atabey N et al (2017) Role of albumin in growth inhibition in hepatocellular carcinoma. Oncology 93(136–14):2
29.
Zurück zum Zitat Nojiri S, Joh T (2014) Albumin suppresses human hepatocellular carcinoma proliferation and the cell cycle. Int J Mol Sci 15(5163–517):4 Nojiri S, Joh T (2014) Albumin suppresses human hepatocellular carcinoma proliferation and the cell cycle. Int J Mol Sci 15(5163–517):4
Metadaten
Titel
Postoperative Albumin–Bilirubin Grade Change Predicts the Prognosis of Patients with Hepatitis B-Related Hepatocellular Carcinoma Within the Milan Criteria
verfasst von
Chuan Li
Xiao-Yun Zhang
Wei Peng
Tian-Fu Wen
Lu-Nan Yan
Bo Li
Jia-Yin Yang
Wen-Tao Wang
Ming-Qing Xu
Publikationsdatum
14.11.2017
Verlag
Springer International Publishing
Erschienen in
World Journal of Surgery / Ausgabe 6/2018
Print ISSN: 0364-2313
Elektronische ISSN: 1432-2323
DOI
https://doi.org/10.1007/s00268-017-4355-2

Weitere Artikel der Ausgabe 6/2018

World Journal of Surgery 6/2018 Zur Ausgabe

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

Karpaltunnelsyndrom BDC Leitlinien Webinare
CME: 2 Punkte

Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.

Prof. Dr. med. Gregor Antoniadis
Berufsverband der Deutschen Chirurgie e.V.

S2e-Leitlinie „Distale Radiusfraktur“

Radiusfraktur BDC Leitlinien Webinare
CME: 2 Punkte

Das Webinar beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?

PD Dr. med. Oliver Pieske
Dr. med. Benjamin Meyknecht
Berufsverband der Deutschen Chirurgie e.V.

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“

Appendizitis BDC Leitlinien Webinare
CME: 2 Punkte

Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.

Dr. med. Mihailo Andric
Berufsverband der Deutschen Chirurgie e.V.